<code id='5E6D0C0469'></code><style id='5E6D0C0469'></style>
    • <acronym id='5E6D0C0469'></acronym>
      <center id='5E6D0C0469'><center id='5E6D0C0469'><tfoot id='5E6D0C0469'></tfoot></center><abbr id='5E6D0C0469'><dir id='5E6D0C0469'><tfoot id='5E6D0C0469'></tfoot><noframes id='5E6D0C0469'>

    • <optgroup id='5E6D0C0469'><strike id='5E6D0C0469'><sup id='5E6D0C0469'></sup></strike><code id='5E6D0C0469'></code></optgroup>
        1. <b id='5E6D0C0469'><label id='5E6D0C0469'><select id='5E6D0C0469'><dt id='5E6D0C0469'><span id='5E6D0C0469'></span></dt></select></label></b><u id='5E6D0C0469'></u>
          <i id='5E6D0C0469'><strike id='5E6D0C0469'><tt id='5E6D0C0469'><pre id='5E6D0C0469'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:874
          Adobe

          Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

          The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

          advertisement

          Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In
          Previous article: Intarcia’s device
          Next article: Medical records are filled with copy

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Lasker Awards 2023: Winners in biomedical research
          Lasker Awards 2023: Winners in biomedical research

          Thewinnersofthe2023LaskerAwardsdistinguishedthemselvesinareasincludingAI-enabledproteinmodeling.Wiki

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Lasker Awards 2023: Winners in biomedical research

          Thewinnersofthe2023LaskerAwardsdistinguishedthemselvesinareasincludingAI-enabledproteinmodeling.Wiki